Betz Stephen F. (CIK 1886575) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-01). Recent activity: Sell CRNX (58,286 shares), Sell CRNX (79,650 shares), Sell CRNX (6,371 shares), Sell CRNX (4,241 shares), Buy CRNX (30,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-01 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Scientific Officer | Sell | 58,286 | $5.0M |
| 2026-09-01 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Scientific Officer | Sell | 79,650 | $6.8M |
| 2026-03-18 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Scientific Officer | Sell | 6,371 | $236,428 |
| 2026-03-18 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Scientific Officer | Sell | 4,241 | $160,183 |
| 2026-02-25 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Scientific Officer | Buy | 30,000 | $0 |
| 2025-12-29 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Scientific Officer | Buy | 18,000 | $34,380 |
| 2025-06-16 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Scientific Officer | Buy | 71,525 | $136,613 |
| 2025-06-16 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Scientific Officer | Buy | 16,645 | $154,466 |
| 2025-06-16 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Scientific Officer | Sell | 97,483 | $3.1M |
Source: SEC Form 4 filings · as of 2026-09-01